DILAUDID
- Product NDC
- 59011-454
- 11-digit product format
- 590110454
- Labeler code
- 59011
- Product ID
- 59011-454_0cc002bd-a7e7-0cd0-bf27-678460984ad5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROMORPHONE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Purdue Pharma LP
- Application
- NDA019892
- Marketing category
- NDA
- Marketing start
- 1956-01-01
- Marketing end
- 0000-00-00
- Substance
- HYDROMORPHONE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59011-454-01 | 2022-07-21 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
| 59011-454-05 | 2022-07-21 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
| 59011-454-10 | 2022-07-21 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
| 59011-454-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
| 59011-454-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
| 59011-454-10 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-54ee-f424-e053-dadaa90a57ce | 3afae8b9-bb24-447a-bc7f-041c8326a438 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 59011-454-01 | EA - Each | 59011-454 | 034cba53-0ad1-4772-b960-84d9ddbc5acb | 1 | 2012-07-24 |
| 59011-454-05 | EA - Each | 59011-454 | 440bd93b-abc0-4812-a348-5922862b518a | 1 | 2012-07-24 |
| 59011-454-10 | EA - Each | 59011-454 | c6c1e5ed-bd41-461c-8567-321f4f035359 | 1 | 2012-07-24 |